| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8680530 | Alzheimer's & Dementia: Translational Research & Clinical Interventions | 2017 | 15 Pages | 
Abstract
												This pilot study is the first trial evaluating the potential benefits of home-based tailored and adaptive CCT in relation to cognitive and disease self-management in older diabetic adults. Methodological strengths of this trial include the double-blind design, the clear identification of the proposed active ingredients of the intervention, and the use of evidence-based behavior-change techniques. Results from this study will indicate whether CCT has the potential to lower the risk of diabetes-related cognitive decline. The outcomes of the trial will also advance our understanding of essential intervention parameters required to improve or maintain cognitive function and enhance disease self-management in this at-risk group.
											Keywords
												
											Related Topics
												
													Life Sciences
													Neuroscience
													Neurology
												
											Authors
												Rachel Bloom, Michal Schnaider-Beeri, Ramit Ravona-Springer, Anthony Heymann, Hai Dabush, Lior Bar, Shirel Slater, Yuri Rassovsky, Alex Bahar-Fuchs, 
											